TY - JOUR
T1 - Shock Index as a predictor for In-hospital mortality in patients with non-ST-segment elevation myocardial infarction
AU - Kobayashi, Akihiro
AU - Misumida, Naoki
AU - Luger, Daniel
AU - Kanei, Yumiko
N1 - Publisher Copyright:
© 2016 Elsevier Inc.
PY - 2015/11/17
Y1 - 2015/11/17
N2 - Background/Purpose Shock index (SI), a ratio of heart rate/systolic blood pressure, has been reported to predict increased mortality in patients with ST-segment elevation myocardial infarction. However, the prognostic value of SI has not been fully elucidated in patients with non-ST-segment elevation myocardial infarction (NSTEMI). Methods/Materials We performed a retrospective analysis of 481 consecutive NSTEMI patients who underwent coronary angiography from January 2013 to June 2014. Systolic blood pressure and heart rate on presentation were recorded, and SI was calculated as heart rate/systolic blood pressure. Patients were divided into those with SI ≧ 0.7 and those with SI < 0.7. Baseline and angiographic characteristics were recorded. In addition, cardiogenic shock and in-hospital mortality were recorded and compared between the two groups. Results Among 481 patients, 103 patients (21.4%) had SI ≧ 0.7. No statistically significant difference was observed in baseline characteristics between the two groups. Patients with SI ≧ 0.7 had a lower left ventricular ejection fraction than those with SI < 0.7 (56 [35–60] % vs. 60 [45–64] %, p = 0.035). Patients with SI ≧ 0.7 had a higher rate of cardiogenic shock on admission (2.9% vs. 0.3%, p = 0.032). Patients with SI ≧ 0.7 had a higher, albeit statistically insignificant, incidence of cardiogenic shock after admission (5.0% vs. 1.9%, p = 0.074). The total incidence of cardiogenic shock was higher in patients with SI ≧ 0.7 (7.8% vs. 2.1%, p = 0.001). Patients with SI ≧ 0.7 had higher in-hospital mortality (4.9% vs. 0.5%, p = 0.006) than those with SI < 0.7. Conclusion Elevated SI was associated with higher in-hospital mortality in patients with NSTEMI.
AB - Background/Purpose Shock index (SI), a ratio of heart rate/systolic blood pressure, has been reported to predict increased mortality in patients with ST-segment elevation myocardial infarction. However, the prognostic value of SI has not been fully elucidated in patients with non-ST-segment elevation myocardial infarction (NSTEMI). Methods/Materials We performed a retrospective analysis of 481 consecutive NSTEMI patients who underwent coronary angiography from January 2013 to June 2014. Systolic blood pressure and heart rate on presentation were recorded, and SI was calculated as heart rate/systolic blood pressure. Patients were divided into those with SI ≧ 0.7 and those with SI < 0.7. Baseline and angiographic characteristics were recorded. In addition, cardiogenic shock and in-hospital mortality were recorded and compared between the two groups. Results Among 481 patients, 103 patients (21.4%) had SI ≧ 0.7. No statistically significant difference was observed in baseline characteristics between the two groups. Patients with SI ≧ 0.7 had a lower left ventricular ejection fraction than those with SI < 0.7 (56 [35–60] % vs. 60 [45–64] %, p = 0.035). Patients with SI ≧ 0.7 had a higher rate of cardiogenic shock on admission (2.9% vs. 0.3%, p = 0.032). Patients with SI ≧ 0.7 had a higher, albeit statistically insignificant, incidence of cardiogenic shock after admission (5.0% vs. 1.9%, p = 0.074). The total incidence of cardiogenic shock was higher in patients with SI ≧ 0.7 (7.8% vs. 2.1%, p = 0.001). Patients with SI ≧ 0.7 had higher in-hospital mortality (4.9% vs. 0.5%, p = 0.006) than those with SI < 0.7. Conclusion Elevated SI was associated with higher in-hospital mortality in patients with NSTEMI.
KW - Cardiogenic shock
KW - Mortality
KW - Shock index
KW - non-ST-segment elevation myocardial infarction
UR - https://www.scopus.com/pages/publications/84960153595
U2 - 10.1016/j.carrev.2016.02.015
DO - 10.1016/j.carrev.2016.02.015
M3 - Article
C2 - 26973283
AN - SCOPUS:84960153595
SN - 1553-8389
VL - 17
SP - 225
EP - 228
JO - Cardiovascular Revascularization Medicine
JF - Cardiovascular Revascularization Medicine
IS - 4
ER -